Lattice Biologics Ltd. (LBLTF)

Market Cap	128.00 -100.0%
Revenue (ttm)	1.56M -28.9%
Net Income	-951.65K
EPS	-0.01
Shares Out	128.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,000
Average Volume	14,628
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	1.21
RSI	41.21
Earnings Date	n/a

About Lattice Biologics

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization,...

• Industry: Medical Devices
• Sector: Healthcare
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: LBLTF

Financial Performance

In fiscal year 2020, Lattice Biologics's revenue was $2.46 million, an increase of 12.60% compared to the previous year's $2.19 million. Losses were -$1.48 million, 46.5% more than in 2019.